Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2b plus ribavirin.

Bibliographic Information

Title
Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2b plus ribavirin.
Author
Hiramatsu N(1番目), Oze T, et. al.

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000782048427278
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top